GlassScriptPhysician profile
Ismet Lukolic
NPI 1275777039
$5,187.08
in general payments reported to CMS, 2019-2025
15 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,857 · 2020: $45.25 · 2021: $72.02 · 2022: $353 · 2023: $698 · 2024: $25.15 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $550 · Food and Beverage: $293 · Education: $16.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $550.44 |
| Food and Beverage | $292.52 |
| Education | $16.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $3,507.77 | 2019-2023 | Visiglide |
| Abbvie INC. | $497.90 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $255.50 | 2019-2023 | Entyvio |
| Gilead Sciences, INC. | $219.64 | 2019 | |
| Olympus America INC. | $169.32 | 2019-2021 | |
| Pfizer INC. | $127.76 | 2022 | |
| Janssen Biotech, INC. | $119.98 | 2019-2025 | Tremfya |
| Intercept Pharmaceuticals, INC. | $72.64 | 2019-2023 | Ocaliva |
| Celgene Corporation | $61.78 | 2022-2023 | Zeposia |
| Ironwood Pharmaceuticals, INC | $44.86 | 2019-2020 | |
| Braintree Laboratories, INC. | $32.38 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $26.20 | 2025 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.19 | 2019 | |
| Merck Sharp & Dohme LLC | $15.60 | 2019 | |
| Dova Pharmaceuticals | $13.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ismet Lukolic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.